Kanagawa, Japan

Tadayuki Nishibe


Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 32(Granted Patents)


Location History:

  • Hiratsuka, JP (2002)
  • Kanagawa, JP (2004 - 2007)

Company Filing History:


Years Active: 2002-2007

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Tadayuki Nishibe: Innovator in Anti-Inflammatory Agents

Introduction

Tadayuki Nishibe is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of anti-inflammatory agents. With a total of 3 patents to his name, Nishibe's work has the potential to impact the pharmaceutical industry positively.

Latest Patents

Nishibe's latest patents include innovative compounds and processes. One of his notable inventions is related to Oxa(thia)zolidine compounds, which outlines a process for their preparation and their use as anti-inflammatory agents. This invention provides medicinal compositions characterized by comprising as the active ingredient either a compound represented by a specific formula or a pharmaceutically acceptable composite thereof. Another significant patent focuses on Oxa(thia)zolidine derivatives and their application as anti-inflammatory drugs.

Career Highlights

Tadayuki Nishibe is currently associated with Nippon Soda Co., Ltd., where he continues to advance his research and development efforts. His work at this esteemed company has allowed him to explore various avenues in medicinal chemistry, contributing to the creation of effective therapeutic agents.

Collaborations

Nishibe has collaborated with several talented individuals in his field, including Masae Takagi and Keiichi Ishimitsu. These collaborations have fostered a productive environment for innovation and have led to the successful development of new medicinal compounds.

Conclusion

Tadayuki Nishibe's contributions to the field of anti-inflammatory agents through his patents and collaborations highlight his role as a significant inventor in medicinal chemistry. His ongoing work promises to yield further advancements in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…